Skip directly to page options Skip directly to A-Z link

Volume 31, Number 7—July 2025

CME ACTIVITY - Research

Multicenter Case–Control Study of Behavioral, Environmental, and Geographic Risk Factors for Talaromycosis, Vietnam

Lottie Brown1Comments to Author , Brian Jonat1, Vo Trieu Ly, Nguyen Le Nhu Tung, Pham Si Lam, Nguyen Tat Thanh, Dang Thi Ngoc Bich, Vu Phuong Thao, Nguyen Thi Mai Thu, Ngo Thi Hoa, and Thuy LeComments to Author 
Author affiliation: City St. George’s Hospital and St. George’s University, London, UK (L. Brown); Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA (B. Jonat); Tropical Medicine Research Center for Talaromycosis, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam (V.T. Ly, N.T. Hoa, T. Le); Hospital for Tropical Diseases, Ho Chi Minh City (V.T. Ly, N.L.N. Tung); Oxford University Clinical Research Unit, Ho Chi Minh City (P.S. Lam, N.T. Thanh, N.T. Hoa); National Hospital for Tropical Diseases, Hanoi, Vietnam (D.T.N. Bich); Saskatchewan Cancer Agency, Regina, Saskatchewan, Canada (V.P. Thao); Duke University Medical Center, Durham, North Carolina, USA (N.T.M. Thu, T. Le)

Main Article

Table 5

Recruited talaromycosis cases per regional HIV population in southern Vietnam in multicenter case–control study of behavioral, environmental, and geographic risk factors for talaromycosis, Vietnam*

Region Talaromycosis cases Estimated HIV population, 2007 Cases/100,000 HIV population
Mekong Delta 17 103,615 16
Ho Chi Minh City 60 72,566 83
Southeast 68 52,132 130
South Central Coast 6 11,878 51
Central Highlands 24 12,123 200

*The number of talaromycosis cases recruited per total HIV population in each region was estimated using HIV prevalence data obtained from the Vietnam Ministry of Health Administration of HIV/AIDS Control from 2007 to evaluate for any bias in referral pattern.

Main Article

1These authors contributed equally to this article.

Page created: June 23, 2025
Page updated: June 23, 2025
Page reviewed: June 23, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external